As per Intent Market Research, the Women Health Devices Market was valued at USD 10.6 billion in 2023 and will surpass USD 21.2 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.
The women’s health devices market is expanding rapidly as healthcare innovations focus on meeting the specific needs of women across various life stages. Devices designed for menstrual health, fertility monitoring, breast cancer screening, pelvic health, and pregnancy tests are integral in providing personalized care. The increasing awareness surrounding women’s health issues, coupled with technological advancements, is driving demand for these devices. A rising number of women are seeking more accessible and non-invasive solutions for managing reproductive health, monitoring menstrual cycles, and diagnosing potential health issues. The market’s growth is also fueled by shifting societal attitudes toward healthcare, including increased focus on wellness and preventive care.
Menstrual Health Devices Segment is Largest Owing to Increasing Awareness and Demand for Personalized Care
The menstrual health devices segment is the largest in the women’s health devices market. With growing awareness surrounding menstruation and its impact on women's health, products designed for menstrual tracking, pain relief, and management are gaining significant traction. Menstrual health devices include smart tampons, menstrual cups, wearable period trackers, and heating pads, offering women personalized solutions to monitor and manage their menstrual cycles. These devices allow for better tracking of cycle irregularities and can help manage conditions such as dysmenorrhea and endometriosis.
The demand for menstrual health devices is growing globally as women increasingly seek non-invasive, sustainable, and efficient ways to monitor their menstrual cycles and manage menstrual disorders. Additionally, the rise in awareness regarding menstrual health, particularly in emerging markets, is contributing to the growth of this segment. As technology continues to evolve, menstrual health devices are becoming more integrated with wearable health solutions, further fueling their widespread adoption.
Wearable Health Devices Segment is Fastest Growing Owing to Increasing Adoption of Personalized Health Monitoring
The wearable health devices segment is growing at the fastest rate within the women’s health devices market. These devices offer women the ability to monitor their health on a continuous basis, with features such as menstrual cycle tracking, fertility tracking, and overall health assessments. Wearable devices, such as fitness trackers and smartwatches, are increasingly integrating features specific to women's health, including pregnancy monitoring, ovulation predictions, and pelvic health monitoring.
Wearables offer convenience and accessibility, enabling real-time monitoring of vital health metrics from the comfort of one's home. The rise of remote health monitoring, especially during the COVID-19 pandemic, has further accelerated the adoption of wearable devices, as they provide a seamless way to track a variety of health parameters. With ongoing advancements in technology, wearables are expected to continue growing in popularity, helping women make informed decisions about their health and wellness.
Gynecology and Obstetrics Application is Largest Owing to High Demand for Reproductive Health Monitoring
The gynecology and obstetrics application segment is the largest in the market for women’s health devices, as the demand for reproductive health monitoring and prenatal care continues to rise. Devices in this segment include tools for monitoring menstrual cycles, fertility, pregnancy, and gynecological health, such as ultrasounds, fertility monitors, and pregnancy tests. These devices are crucial for early diagnosis, helping women better understand and manage their reproductive health and ensuring that gynecological issues are addressed promptly.
With the rise in reproductive health awareness and the growing number of women opting for fertility treatments and prenatal care, the demand for gynecological and obstetric devices is surging. Additionally, the increasing focus on early detection of conditions like breast cancer, uterine fibroids, and ovarian cysts is contributing to the expansion of this segment. As more women seek preventive care and personalized solutions, gynecology and obstetrics devices remain essential in promoting women's health.
North America is Largest Region Owing to Advanced Healthcare Infrastructure and Growing Demand for Women's Health Devices
North America is the largest region in the women’s health devices market, driven by the advanced healthcare infrastructure, high awareness levels, and significant demand for women's health solutions. The U.S. and Canada lead in the adoption of innovative health technologies, including wearable health devices, fertility monitors, and menstrual health solutions. Additionally, the region has a well-established market for gynecological and obstetric devices, with healthcare professionals and women’s health organizations offering education and awareness programs about reproductive health.
North America’s dominance is further fueled by the increasing prevalence of lifestyle diseases affecting women, such as polycystic ovary syndrome (PCOS), endometriosis, and breast cancer, which drives the need for diagnostic devices and treatment options. The growing trend toward preventive healthcare, coupled with an increasing focus on wellness, is expected to continue propelling the region’s market growth. As women’s health continues to gain attention, North America is likely to maintain its position as the leading market for women’s health devices.
Competitive Landscape and Key Players
The women’s health devices market is competitive, with numerous key players focusing on product innovation and strategic partnerships to expand their market reach. Leading companies in the market include Philips Healthcare, Abbott Laboratories, GE Healthcare, Medtronic, and Fitbit. These companies are investing heavily in research and development to create advanced solutions tailored to women’s health needs, such as smart wearables, fertility monitors, and advanced diagnostic tools.
The competitive landscape is also shaped by the increasing focus on personalized health solutions, with companies leveraging artificial intelligence, machine learning, and data analytics to provide women with accurate health monitoring and insights. Furthermore, collaborations with healthcare providers, insurance companies, and health tech startups are helping expand access to innovative women’s health devices globally. As the market continues to grow, competition is expected to intensify, with companies striving to offer more affordable, efficient, and user-friendly solutions to meet the evolving needs of women.
List of Leading Companies:
- Johnson & Johnson
- Abbott Laboratories
- Medtronic
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Hologic, Inc.
- Procter & Gamble (Always)
- Stryker Corporation
- Becton Dickinson and Company
- Thermo Fisher Scientific
- Intuitive Surgical
- FUJIFILM Holdings Corporation
- Ferring Pharmaceuticals
- Hologic, Inc.
Recent Developments:
- Medtronic launched a new pelvic health device for non-invasive treatment of pelvic floor disorders in women.
- Hologic, Inc. announced an acquisition of a fertility monitoring startup to expand its women’s health device portfolio.
- Siemens Healthineers introduced a breast cancer screening device utilizing AI for earlier detection and improved accuracy.
- GE Healthcare partnered with a women’s health company to introduce wearable devices that monitor pregnancy and maternal health.
- Philips Healthcare unveiled an upgraded version of its fertility monitor with enhanced AI capabilities for better tracking of ovulation cycles.
Report Scope:
Report Features |
Description |
Market Size (2023) |
USD 10.6 Billion |
Forecasted Value (2030) |
USD 21.2 Billion |
CAGR (2024 – 2030) |
10.4% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Women Health Devices Market by Product Type (Menstrual Health Devices, Fertility Monitors, Breast Cancer Screening Devices, Pelvic Health Devices, Pregnancy Test Devices), by Technology Type (Wearable Health Devices, Diagnostic Devices), by Application (Gynecology and Obstetrics, Reproductive Health, Menopause Care), and by End-Use Industry (Hospitals, Homecare, Clinics, Diagnostic Laboratories) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Johnson & Johnson, Abbott Laboratories, Medtronic, GE Healthcare, Siemens Healthineers, Philips Healthcare, Procter & Gamble (Always), Stryker Corporation, Becton Dickinson and Company, Thermo Fisher Scientific, Intuitive Surgical, FUJIFILM Holdings Corporation, Hologic, Inc. |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Women Health Devices Market, by Product Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Menstrual Health Devices |
4.2. Fertility Monitors |
4.3. Breast Cancer Screening Devices |
4.4. Pelvic Health Devices |
4.5. Pregnancy Test Devices |
4.6. Others |
5. Women Health Devices Market, by Technology Type (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Wearable Health Devices |
5.2. Diagnostic Devices |
6. Women Health Devices Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Gynecology and Obstetrics |
6.2. Reproductive Health |
6.3. Menopause Care |
6.4. Others |
7. Women Health Devices Market, by End-Use Industry (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Hospitals |
7.2. Homecare |
7.3. Clinics |
7.4. Diagnostic Laboratories |
8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America Women Health Devices Market, by Product Type |
8.2.7. North America Women Health Devices Market, by Technology Type |
8.2.8. North America Women Health Devices Market, by Application |
8.2.9. North America Women Health Devices Market, by End-Use Industry |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US Women Health Devices Market, by Product Type |
8.2.10.1.2. US Women Health Devices Market, by Technology Type |
8.2.10.1.3. US Women Health Devices Market, by Application |
8.2.10.1.4. US Women Health Devices Market, by End-Use Industry |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Johnson & Johnson |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Abbott Laboratories |
10.3. Medtronic |
10.4. GE Healthcare |
10.5. Siemens Healthineers |
10.6. Philips Healthcare |
10.7. Hologic, Inc. |
10.8. Procter & Gamble (Always) |
10.9. Stryker Corporation |
10.10. Becton Dickinson and Company |
10.11. Thermo Fisher Scientific |
10.12. Intuitive Surgical |
10.13. FUJIFILM Holdings Corporation |
10.14. Ferring Pharmaceuticals |
10.15. Hologic, Inc. |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Women Health Devices Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Women Health Devices Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Women Health Devices Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA